Platelet glycoprotein IIb/IIIa inhibitors: Overview and implications for the anesthesiologist

被引：14

作者：

Chun, R

Orser, BA

Madan, M

机构：

[1] Foothills Med Ctr, Dept Anesthesia, Calgary, AB T2N 2T9, Canada

[2] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada

[3] Univ Toronto, Dept Physiol, Toronto, ON, Canada

[4] Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Anesthesia, Toronto, ON, Canada

[5] Sunnybrook & Womens Coll Hlth Sci Ctr, Div Cardiol, Toronto, ON, Canada

来源：

ANESTHESIA AND ANALGESIA | 2002年 / 95卷 / 04期

关键词：

D O I：

10.1097/00000539-200210000-00017

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

引用

页码：879 / 888

页数：10

共 51 条

[1] BLEEDING COMPLICATIONS WITH THE CHIMERIC ANTIBODY TO PLATELET GLYCOPROTEIN IIB/IIIA INTEGRIN IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION [J].

AGUIRRE, FV ;

TOPOL, EJ ;

FERGUSON, JJ ;

ANDERSON, K ;

BLANKENSHIP, JC ;

HEUSER, RR ;

SIGMON, K ;

TAYLOR, M ;

GOTTLIEB, R ;

HANOVICH, G ;

ROSENBERG, M ;

DONOHUE, TJ ;

WEISMAN, HF ;

CALIFF, RM .

CIRCULATION, 1995, 91 (12) :2882-2890

[2] Emergency coronary bypass grafting for failed percutaneous coronary artery stenting: Increased costs and platelet transfusion requirements after the use of abciximab [J].

Alvarez, JM .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 115 (02) :472-473

[3]

Bazzino O, 1998, NEW ENGL J MED, V338, P1498

[4]

Bazzino O, 1998, NEW ENGL J MED, V338, P1488

[5]

Berkowitz SD, 1997, CIRCULATION, V95, P809

[6] Abciximab reduces mortality in diabetics following percutaneous coronary intervention [J].

Bhatt, DL ;

Marso, SP ;

Lincoff, AM ;

Wolski, KE ;

Ellis, SG ;

Topol, EJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (04) :922-928

[7] Vascular access site complications after percutaneous coronary intervention with abciximab in the evaluation of c7E3 for the prevention of ischemic complications (EPIC) trial [J].

Blankenship, JC ;

Hellkamp, AS ;

Aguirre, FV ;

Demko, SL ;

Topol, EJ ;

Califf, RM .

AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (01) :36-40

[8] EFFECTS OF PROFOUND PLATELET INHIBITION WITH C7E3 BEFORE CORONARY ANGIOPLASTY ON COMPLICATIONS OF CORONARY-BYPASS SURVEY [J].

BOEHRER, JD ;

KEREIAKES, DJ ;

NAVETTA, FI ;

CALIFF, RM ;

TOPOL, EJ .

AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (11) :1166-1170

[9] USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].

CALIFF, RM ;

SHADOFF, N ;

VALETT, N ;

BATES, E ;

GALEANA, A ;

KNOPF, W ;

SHAFTEL, J ;

BENDER, MJ ;

AVERSANO, T ;

RAQUENO, J ;

GURBEL, P ;

COWFER, J ;

COHEN, M ;

CROSS, P ;

BITTL, J ;

EDDINGS, K ;

TAYLOR, M ;

DEROSA, K ;

HATTEL, L ;

COOPER, L ;

ESHELMAN, B ;

FINTEL, D ;

NIEMYSKI, P ;

KLEIN, L ;

KENNEDY, H ;

THORNTON, T ;

KEREIAKES, D ;

MARTIN, L ;

ANDERSON, L ;

HIGBY, N ;

ELLIS, S ;

BREZINA, K ;

GEORGE, B ;

CHAPEKIS, A ;

SMITH, D ;

ANWAR, A ;

GERBER, TL ;

PRITCHARD, GL ;

MYLER, R ;

SHAW, R ;

MURPHY, M ;

WARD, K ;

MADIGAN, NP ;

BLANKENSHIP, J ;

HALBERT, M ;

FLANAGAN, C ;

TANNENBAUM, M ;

POLICH, M ;

STEVENSON, C ;

TCHENG, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961

[10] Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban:: Rationale and study design of the international TACTICS-TIMI 18 trial [J].

Cannon, CP ;

Weintraub, WS ;

Demopoulos, LA ;

Robertson, DH ;

Gormley, GJ ;

Braunwald, E .

AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (06) :731-736

← 1 2 3 4 5 6 →